Article Text

other Versions

PDF
Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania
  1. Maria Roura (maria.roura{at}lshtm.ac.uk)
  1. London School of Hygiene & Tropical Medicine, Tanzania, United Republic of
    1. Mark Urassa (malloomark{at}hotmail.com)
    1. NIMR-Mwanza, Tanzania, United Republic of
      1. Joanna Busza (joanna.busza{at}lshtm.ac.uk)
      1. London School of Hygiene & Tropical Medicine, United Kingdom
        1. Doris Mbata (dorismbata{at}yahoo.com)
        1. NIMR-Mwanza, Tanzania, United Republic of
          1. Alison Wringe (alison.wringe{at}lshtm.ac.uk)
          1. London School of Hygiene & Tropical Medicine, United Kingdom
            1. Basia Zaba (basia.zaba{at}lshtm.ac.uk)
            1. London School of Hygiene & Tropical Medicine, United Kingdom

              Abstract

              Objective: to investigate the interplay between antiretroviral therapy (ART) scale-up, different types of stigma, and Voluntary Counselling and Testing (VCT) uptake two years after the introduction of free ART in a rural ward of Tanzania.

              Methods: Qualitative study using in-depth interviews and group activities with a purposive sample of 91 community leaders, 77 ART clients and 16 health providers. Data were analysed for recurrent themes using NVIVO-7 software.

              Results: The complex interplay between ART, stigma, and VCT in this setting is characterised by two powerful but opposing dynamics. The availability of effective treatment has transformed HIV into a manageable condition which is contributing to a reduction of self-stigma and is stimulating VCT uptake. However, this is counter-balanced by the persistence of blaming attitudes and emergence of new sources of stigma associated with ART provision. The general perception among community leaders was that as ART users regained health they increasingly engaged in sexual relations and "spread the disease". Fears were exacerbated because they were perceived to be very mobile and difficult to identify physically. Some leaders suggested giving ART recipients drugs "for impotence", marking them "with a sign", and putting them "in isolation camps". In this context, traditional beliefs about disease aetiology provided a less stigmatised explanation for HIV symptoms contributing to a situation of collective denial.

              Conclusion: Where anticipated stigma prevails, provision of antiretroviral drugs alone is unlikely to have sufficient impact on VCT uptake. Achieving widespread public health benefits of ART roll-out requires community-level interventions to ensure local acceptability of antiretroviral drugs.

              Statistics from Altmetric.com

              Request permissions

              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

              Linked Articles

              • Brief encounters
                Helen Ward Rob Miller